Tilray, Inc. Reports Third Quarter 2019 Financial Results Revenue Increased 409% to $51.1 (C$67.8) Million in the Third Quarter of 2019 Compared to the Prior Year Period International Medical...
This is a copy of the September 15th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, We were speaking this week with the...
In an 8-K filing released after the close, Tilray (NASDAQ: TLRY) announced that Cowen and Company has been selected to sell up to $400 million in stock once an S-3...
Tilray, Inc. and Privateer Holdings, Inc. Sign Definitive Agreement to Extend Lock-up and Provide for Orderly Distribution of 75 Million Tilray Shares Held by Privateer 77 Percent of Tilray’s...
After a 57.4% gain in Q1 followed by a 28.0% pullback in Q2 and 13.8% decline in July, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved sharply...
This is a copy of the September 1st edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, This week, New Cannabis Ventures celebrated a...
Tilray Announces Definitive Agreement to Acquire FOUR20 Adult-Use Cannabis Retailer FOUR20 owns and operates six stores in Alberta and has secured 16 additional high-traffic store locations Agreement is for...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
This is a copy of the August 18th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, We have been very cautious on Cannabis...
Tilray, Inc. Reports Second Quarter 2019 Financial Results Revenue Rises 371.1% to $45.9 (C$60.9) Million in the Second Quarter Compared to the Prior Year Period Canadian Adult-Use Revenue Nearly...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Zenabis Arranges $30 Million Non-Dilutive Financing via Supply Agreement with Tilray® VANCOUVER, July 2, 2019 /CNW/ – Zenabis Global Inc. (TSX:ZENA) (“Zenabis” or the “Company”) today announced that its...
After a 57.4% rebound in Q1 followed by a narrow decline in April and a sharp one in May, Cannabis stocks, as measured by the Global Cannabis Stock Index, moved...
This is a copy of the June 16th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, After a fantastic start to the year,...
Tilray, Inc. and Privateer Holdings, Inc. Sign Letter of Intent to Extend Lock-up and Provide for Orderly Release of 75 Million Tilray Shares Held by Privateer Lock-up to be...
After a 57.4% rebound in Q1 followed by a narrow decline in April, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up substantial ground in May, declining...
Tilray® Boosts International Export Capacity with Manufacturing License and GMP Certification at EU Campus Licensing and certification enhances company’s capacity to export medical cannabis from Portugal to Germany, other...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
This is a copy of the May 19th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, One of the big criticisms of the...
Tilray, Inc. Reports First Quarter 2019 Financial Results Revenue Rises 195.1% to $23.0 (C$31.0) Million in the First Quarter; Company closes two acquisitions: Manitoba Harvest and Natura Naturals NANAIMO,...
Tilray® Announces Investment to Expand Canadian Production and Manufacturing Footprint to Increase Supply of Medical and Adult-Use Cannabis Company plans to add 203,000 square feet at three of its...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
Cannabis stocks, as measured by the Global Cannabis Stock Index, extended their 2019 gains in March, increasing 2.2% to 100.76, leaving the index up 57.4% so far this year: The...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This...
